AzTrials
AzTrials

Chronic Low Back PainCupping-LBPNCT02090686

Pulsatile Cupping in Low Back Pain

A study testing Pulsatile Cupping and Minimal Cupping in people with Chronic Low Back Pain, run by Charite University, Berlin, Germany at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Chronic Low Back Pain
What is being tested?
Pulsatile Cupping and Minimal Cupping
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteGermany
Study dates
Mar 2014to 28 Feb 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Male and female, 18-65 years
  • Chronic low back pain (disease duration > 3 months)
  • Pain intensity on visual analogue scale at inclusion > 40 mm (0-100 mm scale)
  • Only pharmacological treatment with NSAID or no treatment in the last 4 weeks
  • Undersigned informed consent form

Who cannot join

  • Use of anticoagulants (Phenprocoumon, Heparin)
  • Coagulopathy
  • Cupping in the last 6 weeks
  • Other CAM therapies in the last 12 weeks (e.g. acupuncture)
  • Physical therapy in the last 12 weeks (e.g. massage, osteopathy)
  • participation in another study in the last 3 months
Show all 13Show fewer
  • Paracetamol allergy or intolerance
  • Pathological neurological symptoms such as muscular paralysis or paraesthesia due to spinal disc herniation or other causes
  • Known renal and / or hepatic diseases
  • Intake of central nervous system-acting analgesics in the last 6 weeks
  • Applying for early retirement due to low back pain
  • Severe disease that does not allow participation
  • No undersigned informed consent form

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • Charité Universitätsmedizin Berlin

    Berlin, 10117

Other trials in Germany

About this study

Official title: Efficacy of Pulsatile Cupping in Patients With Chronic Low Back Pain - a Randomized Controlled Study.

The purpose of this study is to determine whether pulsatile cupping with a cupping device is effective in the treatment of patients with chronic low back pain compared to no cupping or to minimal cupping.

Being tested
Pulsatile Cupping, Minimal Cupping

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pulsatile CuppingDevice

    Also called HeVaTech PST 30 pulsatile cupping device

    8 cupping sessions (each 8 minutes) in 4 weeks (-150 to -350 mbar), interval 2 seconds.

    Paracetamol on demand as rescue medication (maximum dosage 4 x500 mg/day)

  • Minimal CuppingDevice

    Also called HeVaTech PST 30 pulsatile cupping device

    8 cupping sessions (each 8 minutes) in 4 weeks witth (-60 to -70 mbar). Paracetamol on demand as rescue medication (maximum dosage 4 x500 mg/day).

Study groups in NCT02090686
Study groupRoleWhat they receive
Pulsatile CuppingActive comparatorNot described
Receives: Device: Pulsatile Cupping
Minimal CuppingActive comparatorNot described
Receives: Device: Minimal Cupping
No InterventionNo interventionWaiting list

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intensity of pain on visual analogues scale

    Measured: 4 weeks

Secondary outcomes (6)
  1. Intensity of pain on visual analogue scale

    Measured: 12 weeks

  2. Back function - FFbH-R-Questionnaire

    Measured: 4 weeks, 12 weeks

  3. Quality of Life - SF 36

    Measured: 4 weeks, 12 weeks

  4. Assessment of perceived effect on Likert Scale

    Measured: 4 weeks, 12 weeks

  5. Intake of paracetamol

    Measured: 4 weeks

  6. Adverse events

    Measured: week 1- 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2014 (estimated)
  2. Study startMar 2014
  3. Primary completionOct 2014
  4. Study completion28 Feb 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Masking
Single blind
Who is masked
Participant
Enrolment
110 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02090686
Sponsor's protocol ID
Cupping-LBP
Acronym
Cupping-LBP
Status last verified
Feb 2018
First submitted
17 Mar 2014
Last updated
20 Feb 2018
Results posted
No

Publications

  • Teut M, Ullmann A, Ortiz M, Rotter G, Binting S, Cree M, Lotz F, Roll S, Brinkhaus B. Pulsatile dry cupping in chronic low back pain - a randomized three-armed controlled clinical trial. BMC Complement Altern Med. 2018 Apr 2;18(1):115. doi: 10.1186/s12906-018-2187-8.

    PubMed 29609566

Questions about this trial

What is this clinical trial studying?

A study testing Pulsatile Cupping and Minimal Cupping in people with Chronic Low Back Pain, run by Charite University, Berlin, Germany at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intensity of pain on visual analogues scale (time frame: 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02090686, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Feb 2018; AzTrials last refreshed its copy on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in